Seven Eight Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-19,336
Closed -$1.36M 88
2024
Q3
$1.36M Buy
+19,336
New +$1.36M 0.12% 302
2023
Q4
Sell
-2,653
Closed -$235K 635
2023
Q3
$235K Sell
2,653
-77,146
-97% -$6.83M 0.03% 541
2023
Q2
$6.92M Buy
79,799
+27,310
+52% +$2.37M 1.14% 4
2023
Q1
$5.1M Buy
52,489
+49,051
+1,427% +$4.77M 1.06% 10
2022
Q4
$356K Buy
+3,438
New +$356K 0.09% 278
2022
Q3
Sell
-2,588
Closed -$214K 495
2022
Q2
$214K Sell
2,588
-54,340
-95% -$4.49M 0.09% 325
2022
Q1
$4.39M Buy
56,928
+49,474
+664% +$3.81M 0.59% 39
2021
Q4
$659K Sell
7,454
-36,506
-83% -$3.23M 0.12% 229
2021
Q3
$3.4M Buy
43,960
+34,500
+365% +$2.67M 0.33% 90
2021
Q2
$789K Buy
+9,460
New +$789K 0.11% 321
2020
Q1
Sell
-20,818
Closed -$1.76M 478
2019
Q4
$1.76M Sell
20,818
-15,228
-42% -$1.29M 0.09% 330
2019
Q3
$2.43M Buy
+36,046
New +$2.43M 0.13% 241
2019
Q2
Sell
-8,977
Closed -$797K 585
2019
Q1
$797K Buy
+8,977
New +$797K 0.04% 387
2018
Q4
Sell
-17,977
Closed -$1.74M 546
2018
Q3
$1.74M Buy
17,977
+5,700
+46% +$553K 0.11% 273
2018
Q2
$1.16M Buy
+12,277
New +$1.16M 0.08% 266
2017
Q4
Sell
-2,800
Closed -$261K 458
2017
Q3
$261K Sell
2,800
-32,800
-92% -$3.06M 0.03% 398
2017
Q2
$3.23M Buy
35,600
+33,600
+1,680% +$3.05M 0.46% 63
2017
Q1
$176K Buy
+2,000
New +$176K 0.03% 371
2015
Q4
Sell
-100
Closed -$11K 554
2015
Q3
$11K Buy
+100
New +$11K 0.01% 441
2015
Q2
Sell
-900
Closed -$112K 541
2015
Q1
$112K Buy
+900
New +$112K 0.19% 185
2014
Q3
Sell
-300
Closed -$19K 524
2014
Q2
$19K Buy
+300
New +$19K 0.02% 441